Bioneer Corporation (064550.KQ)
KRW 19520.0
(-3.84%)
KRW 19520.0
(-3.84%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 41.35 Billion KRW | 8.76% |
| 2022 | 38.02 Billion KRW | 43.3% |
| 2021 | 26.53 Billion KRW | 45.28% |
| 2020 | 18.26 Billion KRW | 78.93% |
| 2019 | 10.2 Billion KRW | 24.86% |
| 2018 | 8.17 Billion KRW | -8.25% |
| 2017 | 8.91 Billion KRW | 13.48% |
| 2016 | 7.85 Billion KRW | -15.76% |
| 2015 | 9.32 Billion KRW | -1.96% |
| 2014 | 9.5 Billion KRW | 8.38% |
| 2013 | 8.77 Billion KRW | -7.77% |
| 2012 | 9.51 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 39.16 Billion KRW | -13.13% |
| 2024 Q1 | 45.08 Billion KRW | 9.01% |
| 2023 Q3 | 40.95 Billion KRW | 3.79% |
| 2023 Q4 | 41.35 Billion KRW | 0.97% |
| 2023 Q1 | 38.44 Billion KRW | 1.1% |
| 2023 FY | 41.35 Billion KRW | 8.76% |
| 2023 Q2 | 39.45 Billion KRW | 2.64% |
| 2022 Q3 | 37.98 Billion KRW | 1.6% |
| 2022 FY | 38.02 Billion KRW | 43.3% |
| 2022 Q4 | 38.02 Billion KRW | 0.11% |
| 2022 Q2 | 37.38 Billion KRW | 14.53% |
| 2022 Q1 | 32.64 Billion KRW | 23.03% |
| 2021 Q1 | 19.43 Billion KRW | 6.41% |
| 2021 Q4 | 26.53 Billion KRW | 4.39% |
| 2021 FY | 26.53 Billion KRW | 45.28% |
| 2021 Q3 | 25.41 Billion KRW | -3.33% |
| 2021 Q2 | 26.29 Billion KRW | 35.29% |
| 2020 FY | 18.26 Billion KRW | 78.93% |
| 2020 Q2 | 16.21 Billion KRW | 38.57% |
| 2020 Q3 | 19.1 Billion KRW | 17.81% |
| 2020 Q4 | 18.26 Billion KRW | -4.39% |
| 2020 Q1 | 11.7 Billion KRW | 14.65% |
| 2019 Q1 | 8.64 Billion KRW | 5.77% |
| 2019 Q2 | 8.26 Billion KRW | -4.4% |
| 2019 Q3 | 9.28 Billion KRW | 12.32% |
| 2019 FY | 10.2 Billion KRW | 24.86% |
| 2019 Q4 | 10.2 Billion KRW | 9.95% |
| 2018 Q1 | 9.31 Billion KRW | 4.52% |
| 2018 FY | 8.17 Billion KRW | -8.25% |
| 2018 Q4 | 8.17 Billion KRW | -12.37% |
| 2018 Q3 | 9.32 Billion KRW | -1.38% |
| 2018 Q2 | 9.45 Billion KRW | 1.58% |
| 2017 FY | 8.91 Billion KRW | 13.48% |
| 2017 Q4 | 8.91 Billion KRW | 6.4% |
| 2017 Q3 | 8.37 Billion KRW | 5.5% |
| 2017 Q2 | 7.93 Billion KRW | -0.82% |
| 2017 Q1 | 8 Billion KRW | 1.93% |
| 2016 Q2 | 9.04 Billion KRW | -0.3% |
| 2016 FY | 7.85 Billion KRW | -15.76% |
| 2016 Q3 | 8.45 Billion KRW | -6.58% |
| 2016 Q4 | 7.85 Billion KRW | -7.09% |
| 2016 Q1 | 9.07 Billion KRW | -2.65% |
| 2015 Q1 | 9.25 Billion KRW | -2.68% |
| 2015 Q4 | 9.32 Billion KRW | -0.68% |
| 2015 Q3 | 9.38 Billion KRW | 0.2% |
| 2015 Q2 | 9.36 Billion KRW | 1.22% |
| 2015 FY | 9.32 Billion KRW | -1.96% |
| 2014 Q2 | 9.29 Billion KRW | 0.12% |
| 2014 Q3 | 9.5 Billion KRW | 2.3% |
| 2014 Q4 | 9.5 Billion KRW | 0.01% |
| 2014 Q1 | 9.28 Billion KRW | 5.81% |
| 2014 FY | 9.5 Billion KRW | 8.38% |
| 2013 FY | 8.77 Billion KRW | -7.77% |
| 2013 Q4 | 8.77 Billion KRW | -2.1% |
| 2013 Q3 | 8.95 Billion KRW | -9.0% |
| 2013 Q2 | 9.84 Billion KRW | 1.67% |
| 2013 Q1 | 9.68 Billion KRW | 1.82% |
| 2012 FY | 9.51 Billion KRW | 0.0% |
| 2012 Q4 | 9.51 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | -262.072% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -3990.012% |
| BINEX Co., Ltd. | 28.26 Billion KRW | -46.328% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -2064.573% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | -184.87% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -2559.795% |
| Helixmith Co., Ltd | 914.11 Million KRW | -4423.974% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | -21.215% |
| Medy-Tox Inc. | 59.61 Billion KRW | 30.634% |
| Peptron, Inc. | 172.18 Million KRW | -23917.026% |
| Amicogen, Inc. | 46.83 Billion KRW | 11.707% |
| Genexine, Inc. | 3.8 Billion KRW | -986.288% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -675.032% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -20909.684% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -3770.822% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 17.674% |
| SillaJen, Inc. | 1.21 Billion KRW | -3310.312% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | -224.579% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -8728.665% |
| Genomictree Inc. | 496.53 Million KRW | -8228.634% |
| MedPacto, Inc. | 620.00 KRW | -6670045578.71% |
| D&D Pharmatech | 3.45 Billion KRW | -1098.599% |
| EASY BIO,Inc. | 25.93 Billion KRW | -59.432% |
| GI Innovation, Inc. | - KRW | -Infinity% |